All Stories

  1. A Phase I/II Trial of Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy for High-Risk Prostate Cancer (FASTR-2): Preliminary Results and Toxicity Analysis
  2. Radiobiologically Guided Radiation Therapy in Large Primary and Metastatic Hepatic Lesions
  3. The Utility of Penile Bulb Contouring to Localise the Prostate Apex as Compared to Urethrography
  4. Potential benefit of rotational radiation therapy
  5. A multivariable model to predict survival for patients with hepatic carcinoma or liver metastasis receiving radiotherapy
  6. Computed tomography imaging assessment of postexternal beam radiation changes of the liver
  7. 92: Identification of Patients that will not Benefit from Hepatic Radiation
  8. Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions
  9. A Single Institution Consensus on the Use of Sequential or Concurrent Hormonal Therapy for Breast Cancer Patients Receiving Radiation Therapy
  10. Evaluation of Health Economics in Radiation Oncology: A Systematic Review
  11. A Systematic Review of Health Economic Evaluations in Radiation Oncology
  12. Concurrent or Sequential Hormonal and Radiation Therapy in Breast Cancer: A Literature Review.
  13. Abscopal Effects: Case Report and Emerging Opportunities
  14. How has SBRT progressed in different countries and what this can teach us in the future
  15. The significance of circulating tumor cells in prostate cancer patients undergoing adjuvant or salvage radiation therapy
  16. A Phase 1/2 Trial of Brief Androgen Suppression and Stereotactic Radiation Therapy (FASTR) for High-Risk Prostate Cancer
  17. Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma
  18. In Regard to Parikh et al
  19. Dosimetric Comparison of Volumetric Modulated Arc Therapy, Tomotherapy, and Intensity Modulated Radiation Therapy for Radiation Dose Escalation of Hepatic Malignancies
  20. Identification of Patients With Liver Cancer That Will Not Benefit From Radiation
  21. Dynamic contrast enhanced CT aiding gross tumor volume delineation of liver tumors: An interobserver variability study
  22. Phase 1 Study of Image-Guided and Radiobiologically-Guided Stereotactic Body Radiation Therapy for Hepatic Lesions
  23. Improving the Efficiency of Radiation Therapy Delivery by Resource Optimization
  24. Radiotherapy for Liver Metastases: A Review of Evidence
  25. The Impact of Post-Mastectomy Radiation Therapy on Male Breast Cancer Patients—A Case Series
  26. Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy
  27. A Phase II Trial of Arc-Based Hypofractionated Intensity-Modulated Radiotherapy in Localized Prostate Cancer
  28. Phase I Trial of Simultaneous In-Field Boost With Helical Tomotherapy for Patients With One to Three Brain Metastases
  29. Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip
  30. Technology assessment of automated atlas based segmentation in prostate bed contouring
  31. Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy
  32. Systematic review of dose–volume parameters in the prediction of esophagitis in thoracic radiotherapy
  33. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer
  34. Correlation of Clinically Significant Radiation Esophagitis With Dose-Volume Histogram Parameters in Lung Cancer
  35. A Prospective Evaluation of Helical Tomotherapy
  36. 2840
  37. 2322
  38. 2327
  39. A comparison of prostate IMRT and helical tomotherapy class solutions
  40. 23 An NTCP formalism accounting for complications from radiation treatment and tumour invasion
  41. Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy
  42. 22 Development find Psychometric Properties of the Prostate Cancer Radiation Toxicity Questionnaire
  43. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer
  44. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies
  45. Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review